- Anxiety
- Depression
- Alzheimer's Disease
- Weight Loss
- Heart Disease
- Cancer
- Asthma
Trial Phase
Trial Status
Paid Participation
Clear All
33 Safety And Tolerability Trials Near You
Power is an online platform that helps thousands of Safety And Tolerability patients discover FDA-reviewed trials every day. Every trial we feature meets safety and ethical standards, giving patients an easy way to discover promising new treatments in the research stage.
Learn More About PowerCarbetocin Nasal Spray for Prader-Willi Syndrome
Trial Details
Key Eligibility Criteria
160 Participants Needed
Upadacitinib for Crohn's Disease
Trial Details
Key Eligibility Criteria
107 Participants Needed
Long-acting Cabotegravir + Rilpivirine for HIV
Trial Details
Key Eligibility Criteria
1049 Participants Needed
MenABCWY Vaccine for Meningococcal Meningitis
Trial Details
Key Eligibility Criteria
300 Participants Needed
JTT-861 for Heart Failure
Trial Details
Key Eligibility Criteria
300 Participants Needed
GSK3915393 for Pulmonary Fibrosis
Trial Details
Key Eligibility Criteria
150 Participants Needed
ASP2138 for Digestive System Cancers
Trial Details
Key Eligibility Criteria
378 Participants Needed
GSK3858279 for Diabetic Neuropathy
Trial Details
Key Eligibility Criteria
145 Participants Needed
CAB ULA for HIV Infection
Trial Details
Key Eligibility Criteria
69 Participants Needed
AMG 305 for Solid Tumors
Trial Details
Key Eligibility Criteria
220 Participants Needed
NT-I7 for Progressive Multifocal Leukoencephalopathy
Trial Details
Key Eligibility Criteria
18 Participants Needed
Empagliflozin for Heart Transplant Recipients
Trial Details
Key Eligibility Criteria
200 Participants Needed
AZD9291 Combinations for Non-Small Cell Lung Cancer
Trial Details
Key Eligibility Criteria
344 Participants Needed
AZD9833 Combinations for Advanced Breast Cancer
Trial Details
Key Eligibility Criteria
396 Participants Needed
AZD4076 for Healthy Male Subjects
Trial Details
Key Eligibility Criteria
40 Participants Needed
Combination Therapy for Pancreatic Cancer
Trial Details
Key Eligibility Criteria
104 Participants Needed
LY3841136 + Tirzepatide for Obesity
Trial Details
Key Eligibility Criteria
96 Participants Needed
BOS-580 for Nonalcoholic Steatohepatitis (NASH)
Trial Details
Key Eligibility Criteria
231 Participants Needed
Long-Acting Cabotegravir + rHuPH20 for HIV Infection
Trial Details
Key Eligibility Criteria
180 Participants Needed
Oral E-B-FAHF-2 for Crohn's Disease
Trial Details
Key Eligibility Criteria
28 Participants Needed
Why Other Patients Applied
"I've been struggling with ADHD and anxiety since I was 9 years old. I'm currently 30. I really don't like how numb the medications make me feel. And especially now, that I've lost my grandma and my aunt 8 days apart, my anxiety has been even worse. So I'm trying to find something new."
"My orthopedist recommended a half replacement of my right knee. I have had both hips replaced. Currently have arthritis in knee, shoulder, and thumb. I want to avoid surgery, and I'm open-minded about trying a trial before using surgery as a last resort."
"I've tried several different SSRIs over the past 23 years with no luck. Some of these new treatments seem interesting... haven't tried anything like them before. I really hope that one could work."
"As a healthy volunteer, I like to participate in as many trials as I'm able to. It's a good way to help research and earn money."
"I was diagnosed with stage 4 pancreatic cancer three months ago, metastatic to my liver, and I have been receiving and responding well to chemotherapy. My blood work revealed that my tumor markers have gone from 2600 in the beginning to 173 as of now, even with the delay in treatment, they are not going up. CT Scans reveal they have been shrinking as well. However, chemo is seriously deteriorating my body. I have 4 more treatments to go in this 12 treatment cycle. I am just interested in learning about my other options, if any are available to me."
Long-Acting VH4524184 for HIV
Trial Details
Key Eligibility Criteria
72 Participants Needed
Deoxycytidine + Deoxythymidine for Telomere Biology Disorder
Trial Details
Key Eligibility Criteria
36 Participants Needed
JSB462 + Abiraterone for Prostate Cancer
Trial Details
Key Eligibility Criteria
150 Participants Needed
TBD11 Safety Study in Healthy Adults
Trial Details
Key Eligibility Criteria
108 Participants Needed
ASP5502 for Sjögren's Syndrome
Trial Details
Key Eligibility Criteria
132 Participants Needed
Trial Details
Key Eligibility Criteria
64 Participants Needed
Thymus Nuclear Extract for Healthy Individuals
Trial Details
Key Eligibility Criteria
80 Participants Needed
MDI-2517 for Safety and Tolerability
Trial Details
Key Eligibility Criteria
64 Participants Needed
Y-3 for Safety Evaluation
Trial Details
Key Eligibility Criteria
20 Participants Needed
IPG7236 for Advanced Cancer
Trial Details
Key Eligibility Criteria
196 Participants Needed
Know someone looking for new options?
Spread the word
Learn More About Power
We started Power when my dad was diagnosed with multiple myeloma, and I struggled to help him access the latest immunotherapy. Hopefully Power makes it simpler for you to explore promising new treatments, during what is probably a difficult time.
Frequently Asked Questions
How much do Safety And Tolerability clinical trials pay?
Each trial will compensate patients a different amount, but $50-100 for each visit is a fairly common range for Phase 2–4 trials (Phase 1 trials often pay substantially more). Further, most trials will cover the costs of a travel to-and-from the clinic.
How do Safety And Tolerability clinical trials work?
After a researcher reviews your profile, they may choose to invite you in to a screening appointment, where they'll determine if you meet 100% of the eligibility requirements. If you do, you'll be sorted into one of the treatment groups, and receive your study drug. For some trials, there is a chance you'll receive a placebo. Across Safety And Tolerability trials 30% of clinical trials have a placebo. Typically, you'll be required to check-in with the clinic every month or so. The average trial length for Safety And Tolerability is 12 months.
How do I participate in a study as a "healthy volunteer"?
Not all studies recruit healthy volunteers: usually, Phase 1 studies do. Participating as a healthy volunteer means you will go to a research facility several times over a few days or weeks to receive a dose of either the test treatment or a "placebo," which is a harmless substance that helps researchers compare results. You will have routine tests during these visits, and you'll be compensated for your time and travel, with the number of appointments and details varying by study.
What does the "phase" of a clinical trial mean?
The phase of a trial reveals what stage the drug is in to get approval for a specific condition. Phase 1 trials are the trials to collect safety data in humans. Phase 2 trials are those where the drug has some data showing safety in humans, but where further human data is needed on drug effectiveness. Phase 3 trials are in the final step before approval. The drug already has data showing both safety and effectiveness. As a general rule, Phase 3 trials are more promising than Phase 2, and Phase 2 trials are more promising than phase 1.
Do I need to be insured to participate in a Safety And Tolerability medical study?
Clinical trials are almost always free to participants, and so do not require insurance. The only exception here are trials focused on cancer, because only a small part of the typical treatment plan is actually experimental. For these cancer trials, participants typically need insurance to cover all the non-experimental components.
What are the newest Safety And Tolerability clinical trials?
Most recently, we added Empagliflozin for Heart Transplant Recipients, JSB462 + Abiraterone for Prostate Cancer and Deoxycytidine + Deoxythymidine for Telomere Biology Disorder to the Power online platform.